Navaja, Baby Girl .

HRN: 28-31-68  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/30/2025
GENTAMICIN 40MG/ML, 2ML (AMP)
12/30/2025
01/06/2026
IV
15mg
Q24
PSNB (PROM X 15hrs)
Checking Initial Appropriateness 

 Indication:  ProphylaxisEmpiric    Type of Infection:  Unspecified Sepsis    Compliance to guidelines: Compliant To Guidelines